Management of Hypertension in Elderly Patients with CKD

Introduction to Guideline Recommendations

The American College of Cardiology recommends a target blood pressure of <130/80 mmHg for patients with CKD stage 3B, with individualization based on recent AKI and elderly status 1, 2
The Kidney Disease Outcomes Quality Initiative acknowledges that an SBP goal of <130 mmHg may be reasonable for many older individuals with non-dialysis-dependent CKD, emphasizing management must account for tolerance to BP lowering 2, 3

A gradual, stepped-care approach is recommended rather than aggressive dual therapy initiation in elderly patients with SBP ≥150 mmHg to minimize adverse events 2, 3
Close monitoring of patient symptoms, electrolyte levels, and kidney function is essential when treating elderly patients to SBP <130 mmHg 2, 3
The American Journal of Kidney Diseases suggests adding an ACE inhibitor or ARB for patients with albuminuria ≥300 mg/24 hours, as this is a Class 1B recommendation for both diabetic and non-diabetic adults with CKD 4

Chlorthalidone 12.5 mg daily is recommended as a first-line thiazide diuretic for elderly hypertension, with a robust mortality benefit 5
Amlodipine 2.5-5 mg daily is an alternative option if thiazide diuretics are contraindicated due to hyponatremia concerns 5
Lisinopril 5 mg daily or losartan 25 mg daily can be added if albuminuria ≥300 mg/24 hours, starting low in elderly patients with CKD 4, 1

Orthostatic hypotension screening should always measure BP in both sitting and standing positions in elderly patients to assess for orthostatic hypotension 4, 6
Electrolyte monitoring is crucial, particularly sodium levels weekly for the first month if adding thiazide diuretic, and potassium levels every 2-4 weeks initially 5, 2, 3
Kidney function monitoring should check serum creatinine and eGFR within 2-4 weeks after medication initiation or dose changes 5

Recent AKI increases the risk of CKD progression, making BP control even more important, and prevention of repeated AKI is critical 1
Hyponatremia history requires careful consideration, with thiazide diuretic initiation at the lowest dose and close monitoring of sodium levels 5
CKD stage 3B implications include a substantially elevated cardiovascular risk, and drug dosing adjustments may be needed 1

The European Society of Cardiology recommends lowering systolic BP to 130-139 mmHg in patients with diabetic or non-diabetic CKD, with individualized treatment based on tolerability and impact on renal function and electrolytes 7
For elderly patients (≥65 years) with CKD and moderate-to-severe disease (eGFR >30 mL/min/1.73 m²), a more intensive target of 120-129 mmHg may be considered if well-tolerated 7
The Kidney Disease Outcomes Quality Initiative supports an SBP target <130 mmHg for noninstitutionalized ambulatory community-dwelling adults ≥65 years, but emphasizes that clinical judgment and team-based assessment are reasonable for elderly patients with high comorbidity burden 8
Avoid reducing diastolic BP below 80 mmHg, as excessive diastolic lowering can increase cardiovascular risk 7

The European Society of Cardiology recommends RAS blockers (ACE inhibitors or ARBs) as part of the treatment strategy in hypertensive patients with microalbuminuria or proteinuria 7
The Kidney Disease: Improving Global Outcomes guideline strongly recommends ACE inhibitors or ARBs in the setting of severely increased urine albumin excretion 8
The European Society of Cardiology recommends thiazide-type diuretics or calcium channel blockers as appropriate first-line options for elderly patients without significant proteinuria 7

The Kidney Disease Outcomes Quality Initiative suggests targeting the higher end of the BP range (130-139 mmHg systolic) to minimize treatment-related harms in frail elderly patients with multiple comorbidities, limited life expectancy, or frequent falls 8
Clinical judgment regarding intensity of BP lowering is reasonable for elderly patients with high comorbidity burden and limited life expectancy 8

The American College of Cardiology and American Heart Association recommend a blood pressure target of <130/80 mmHg for patients with chronic kidney disease, but this target must be balanced against the risks of excessive blood pressure lowering in elderly, multimorbid patients 9
The risk of driving diastolic blood pressure too low when attempting to achieve systolic targets <120 mmHg is particularly problematic in older patients with advanced atherosclerosis, who often have low diastolic blood pressure at baseline 10

The American College of Cardiology recommends aiming for a systolic blood pressure of 130-139 mmHg and a diastolic blood pressure of 70-80 mmHg in elderly, multimorbid patients to balance cardiovascular protection with avoidance of hypotension-related complications 10

Polypharmacy is common in elderly chronic kidney disease patients and contributes to excessive blood pressure lowering, and this patient likely requires fewer antihypertensive medications than currently prescribed 10